Boditech Med Inc. (KOSDAQ:206640)
South Korea · Delayed Price · Currency is KRW 10,080
-50 (-0.49%)
Sep 1, 2026, 3:30 PM KST
Boditech Med Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 25,990 | 23,653 | 27,260 | 25,947 | 24,152 | 44,367 |
Depreciation & Amortization | 10,139 | 10,062 | 8,442 | 8,232 | 7,473 | 6,041 |
Loss (Gain) From Sale of Assets | 101.81 | 13.66 | 48.52 | -317.25 | -43.62 | 86.54 |
Asset Writedown & Restructuring Costs | 519.24 | 519.24 | - | - | 35.86 | 79.44 |
Loss (Gain) From Sale of Investments | -490.24 | -226.04 | -563.78 | -415.34 | -59.87 | 63.47 |
Loss (Gain) on Equity Investments | -776.21 | 1,452 | 497.31 | 113.95 | 390.07 | 407.01 |
Stock-Based Compensation | -52.45 | -130.88 | -66.32 | 221.53 | 110.36 | 56.51 |
Provision & Write-off of Bad Debts | 353.51 | 345.36 | 472.51 | 2,587 | 638.81 | 4,689 |
Other Operating Activities | -1,020 | -1,509 | -2,862 | 4,161 | -4,804 | -660.03 |
Change in Accounts Receivable | -14,167 | -9,778 | -3,070 | -10,487 | 2,184 | 4,914 |
Change in Inventory | -6,599 | -4,240 | -7,879 | -2,001 | -896.01 | -9,330 |
Change in Accounts Payable | 6,395 | 233.98 | 865.45 | 6,027 | -5,446 | 843.28 |
Change in Other Net Operating Assets | 237.98 | 1,687 | 1,733 | 231.81 | -664.24 | -1,629 |
Operating Cash Flow | 20,631 | 22,081 | 24,879 | 34,300 | 23,068 | 49,927 |
Operating Cash Flow Growth | -24.89% | -11.24% | -27.47% | 48.69% | -53.80% | 11.84% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -36,072 | -33,013 | -11,427 | -4,605 | -15,260 | -18,230 |
Sale of Property, Plant & Equipment | 439.79 | 49.75 | 1,433 | 174.6 | 312.74 | 182.5 |
Cash Acquisitions | -259.72 | -259.72 | - | - | - | - |
Divestitures | - | - | - | 181.79 | - | 248.48 |
Sale (Purchase) of Intangibles | -768.93 | -1,007 | -1,041 | -1,025 | -1,595 | -181.71 |
Investment in Securities | 10,647 | -14,492 | -890.91 | -10,944 | -7,592 | 2,220 |
Other Investing Activities | 420.56 | 420.56 | -51.96 | 95.61 | -320.35 | 157.44 |
Investing Cash Flow | -25,593 | -48,301 | -11,978 | -16,122 | -24,454 | -15,603 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 20,331 | 16,302 | 15,872 | 4,884 | 800 |
Long-Term Debt Repaid | - | -14,923 | -18,009 | -14,739 | -3,698 | -7,033 |
Net Debt Issued (Repaid) | 5,105 | 5,409 | -1,706 | 1,133 | 1,186 | -6,233 |
Issuance of Common Stock | 3,525 | 12.3 | 135.3 | 12.3 | 141.8 | 24.68 |
Repurchase of Common Stock | -4,990 | -4,977 | -2,964 | - | -7,219 | -8,750 |
Dividends Paid | -3,267 | -3,267 | -4,395 | -3,295 | -4,270 | -4,609 |
Other Financing Activities | 1,140 | 1,040 | 954.36 | 212.23 | -0 | -369.26 |
Financing Cash Flow | 1,512 | -1,784 | -7,976 | -1,938 | -10,162 | -19,937 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -207.52 | -384.83 | 525.64 | -7.28 | -1,008 | 383.97 |
Net Cash Flow | -3,658 | -28,388 | 5,450 | 16,232 | -12,555 | 14,772 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15,441 | -10,932 | 13,452 | 29,695 | 7,808 | 31,697 |
Free Cash Flow Growth | - | - | -54.70% | 280.32% | -75.37% | -21.86% |
Free Cash Flow Margin | -9.31% | -6.74% | 9.74% | 22.12% | 6.61% | 20.10% |
Free Cash Flow Per Share | -713.26 | -504.42 | 612.87 | 1351.72 | 349.13 | 1383.14 |
Levered Free Cash Flow | -24,343 | -18,337 | 583.71 | 23,582 | -530.46 | 17,557 |
Unlevered Free Cash Flow | -24,034 | -18,080 | 804.03 | 23,801 | -403.01 | 17,680 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 511.34 | 359.83 | 340.04 | 336.82 | 64.63 | 158.79 |
Cash Income Tax Paid | 5,270 | 6,578 | 6,190 | 2,672 | 8,036 | 11,879 |
Change in Working Capital | -14,134 | -12,097 | -8,350 | -6,229 | -4,823 | -5,202 |